ICCC
Price:
$10.75
Market Cap:
$97.25M
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which sp...[Read more]
Industry
Biotechnology
IPO Date
1987-05-05
Stock Exchange
NASDAQ
Ticker
ICCC
According to ImmuCell Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -179.17. This represents a change of 960.33% compared to the average of -16.90 of the last 4 quarters.
The mean historical PE Ratio of ImmuCell Corporation over the last ten years is -116.97. The current -179.17 PE Ratio has changed 15.22% with respect to the historical average. Over the past ten years (40 quarters), ICCC's PE Ratio was at its highest in in the December 2016 quarter at 239.92. The PE Ratio was at its lowest in in the June 2016 quarter at -784.09.
Average
-116.97
Median
-23.46
Minimum
-776.71
Maximum
49.58
Discovering the peaks and valleys of ImmuCell Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.73%
Maximum Annual PE Ratio = 49.58
Minimum Annual Increase = -622.94%
Minimum Annual PE Ratio = -776.71
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -51.25 | 158.74% |
| 2024 | -19.81 | 191.86% |
| 2023 | -6.79 | -64.40% |
| 2022 | -19.06 | -97.55% |
| 2021 | -776.71 | 1.73% |
| 2020 | -42.50 | 56.80% |
| 2019 | -27.11 | 61.56% |
| 2018 | -16.78 | -93.53% |
| 2017 | -259.29 | -622.94% |
| 2016 | 49.58 | 163.04% |
The current PE Ratio of ImmuCell Corporation (ICCC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-25.95
5-year avg
-174.72
10-year avg
-116.97
ImmuCell Corporation’s PE Ratio is less than Equillium, Inc. (-5.82), less than Cue Biopharma, Inc. (-4.83), less than Outlook Therapeutics, Inc. (-0.75), less than Coeptis Therapeutics Holdings, Inc. (-1.68), less than OS Therapies Incorporated (-1.50), less than NRx Pharmaceuticals, Inc. (-2.38), less than Fortress Biotech, Inc. (0.72), less than Century Therapeutics, Inc. (-1.57), less than Senti Biosciences, Inc. (-0.19), less than Genenta Science S.p.A. (-3.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.82 | $77.79M | |
| -4.83 | $70.03M | |
| -0.75 | $124.49M | |
| -1.68 | $38.62M | |
| -1.50 | $72.86M | |
| -2.38 | $52.81M | |
| 0.72 | $92.68M | |
| -1.57 | $169.68M | |
| -0.19 | $11.62M | |
| -3.49 | $25.46M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuCell Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ImmuCell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ImmuCell Corporation's PE Ratio?
How is the PE Ratio calculated for ImmuCell Corporation (ICCC)?
What is the highest PE Ratio for ImmuCell Corporation (ICCC)?
What is the 3-year average PE Ratio for ImmuCell Corporation (ICCC)?
What is the 5-year average PE Ratio for ImmuCell Corporation (ICCC)?
How does the current PE Ratio for ImmuCell Corporation (ICCC) compare to its historical average?